These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


398 related items for PubMed ID: 11784151

  • 1. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
    Sun X, Wuest M, Weisman GR, Wong EH, Reed DP, Boswell CA, Motekaitis R, Martell AE, Welch MJ, Anderson CJ.
    J Med Chem; 2002 Jan 17; 45(2):469-77. PubMed ID: 11784151
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.
    Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, Anderson CJ.
    J Med Chem; 2004 Mar 11; 47(6):1465-74. PubMed ID: 14998334
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.
    Sprague JE, Peng Y, Sun X, Weisman GR, Wong EH, Achilefu S, Anderson CJ.
    Clin Cancer Res; 2004 Dec 15; 10(24):8674-82. PubMed ID: 15623652
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms.
    Ferdani R, Stigers DJ, Fiamengo AL, Wei L, Li BT, Golen JA, Rheingold AL, Weisman GR, Wong EH, Anderson CJ.
    Dalton Trans; 2012 Feb 21; 41(7):1938-50. PubMed ID: 22170043
    [Abstract] [Full Text] [Related]

  • 6. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
    Cai H, Li Z, Huang CW, Park R, Shahinian AH, Conti PS.
    Nucl Med Biol; 2010 Jan 21; 37(1):57-65. PubMed ID: 20122669
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers.
    Dale AV, An GI, Pandya DN, Ha YS, Bhatt N, Soni N, Lee H, Ahn H, Sarkar S, Lee W, Huynh PT, Kim JY, Gwon MR, Kim SH, Park JG, Yoon YR, Yoo J.
    Inorg Chem; 2015 Sep 08; 54(17):8177-86. PubMed ID: 26286436
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling.
    Boswell CA, Regino CA, Baidoo KE, Wong KJ, Bumb A, Xu H, Milenic DE, Kelley JA, Lai CC, Brechbiel MW.
    Bioconjug Chem; 2008 Jul 08; 19(7):1476-84. PubMed ID: 18597510
    [Abstract] [Full Text] [Related]

  • 9. In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands.
    Sun X, Kim J, Martell AE, Welch MJ, Anderson CJ.
    Nucl Med Biol; 2004 Nov 08; 31(8):1051-9. PubMed ID: 15607487
    [Abstract] [Full Text] [Related]

  • 10. Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS.
    Boswell CA, McQuade P, Weisman GR, Wong EH, Anderson CJ.
    Nucl Med Biol; 2005 Jan 08; 32(1):29-38. PubMed ID: 15691659
    [Abstract] [Full Text] [Related]

  • 11. The in vivo behavior of copper-64-labeled azamacrocyclic complexes.
    Jones-Wilson TM, Deal KA, Anderson CJ, McCarthy DW, Kovacs Z, Motekaitis RJ, Sherry AD, Martell AE, Welch MJ.
    Nucl Med Biol; 1998 Aug 08; 25(6):523-30. PubMed ID: 9751418
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.
    Wei L, Butcher C, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Lewis JS.
    J Nucl Med; 2007 Jan 08; 48(1):64-72. PubMed ID: 17204700
    [Abstract] [Full Text] [Related]

  • 13. Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development.
    De Silva RA, Jain S, Lears KA, Chong HS, Kang CS, Sun X, Rogers BE.
    Nucl Med Biol; 2012 Nov 08; 39(8):1099-104. PubMed ID: 22743158
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution.
    Yoo J, Reichert DE, Welch MJ.
    J Med Chem; 2004 Dec 16; 47(26):6625-37. PubMed ID: 15588098
    [Abstract] [Full Text] [Related]

  • 15. Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes.
    Cutler CS, Wuest M, Anderson CJ, Reichert DE, Sun Y, Martell AE, Welch MJ.
    Nucl Med Biol; 2000 May 16; 27(4):375-80. PubMed ID: 10938473
    [Abstract] [Full Text] [Related]

  • 16. The long and short of it: the influence of N-carboxyethyl versusN-carboxymethyl pendant arms on in vitro and in vivo behavior of copper complexes of cross-bridged tetraamine macrocycles.
    Heroux KJ, Woodin KS, Tranchemontagne DJ, Widger PC, Southwick E, Wong EH, Weisman GR, Tomellini SA, Wadas TJ, Anderson CJ, Kassel S, Golen JA, Rheingold AL.
    Dalton Trans; 2007 Jun 07; (21):2150-62. PubMed ID: 17514336
    [Abstract] [Full Text] [Related]

  • 17. Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.
    Cooper MS, Ma MT, Sunassee K, Shaw KP, Williams JD, Paul RL, Donnelly PS, Blower PJ.
    Bioconjug Chem; 2012 May 16; 23(5):1029-39. PubMed ID: 22471317
    [Abstract] [Full Text] [Related]

  • 18. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.
    Guo Y, Ferdani R, Anderson CJ.
    Bioconjug Chem; 2012 Jul 18; 23(7):1470-7. PubMed ID: 22663248
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
    Chong HS, Milenic DE, Garmestani K, Brady ED, Arora H, Pfiester C, Brechbiel MW.
    Nucl Med Biol; 2006 May 18; 33(4):459-67. PubMed ID: 16720237
    [Abstract] [Full Text] [Related]

  • 20. Hexadentate bispidine derivatives as versatile bifunctional chelate agents for copper(II) radioisotopes.
    Juran S, Walther M, Stephan H, Bergmann R, Steinbach J, Kraus W, Emmerling F, Comba P.
    Bioconjug Chem; 2009 Feb 18; 20(2):347-59. PubMed ID: 19173600
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.